Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    15673801 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Rituximab Vasculitis Maintenance Study
Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis;   Microscopic Polyangiitis;   Wegener Granulomatosis
Interventions: Biological: Rituximab;   Drug: Azathioprine
2 Completed
Has Results
Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis
Condition: Wegener's Granulomatosis
Intervention: Drug: Abatacept

Indicates status has not been verified in more than two years